{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:28:32Z","timestamp":1789918112060,"version":"4.0.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":577,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The role of the cytokine, macrophage migration inhibitory factor (MIF), and its receptor, CD74, was assessed in autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Two<\/jats:bold>\n                                 <jats:bold>\n                                    MIF\n                                 <\/jats:bold>\n                                 <jats:bold>promoter polymorphisms, a functional \u2212794 CATT5\u20138 microsatellite repeat (<\/jats:bold>\n                                 <jats:bold>\n                                    rs5844572\n                                 <\/jats:bold>\n                                 <jats:bold>) and a \u2212173 G\/C single-nucleotide polymorphism (<\/jats:bold>\n                                 <jats:bold>\n                                    rs755622\n                                 <\/jats:bold>\n                                 <jats:bold>), were analyzed in DNA samples from over 500 patients with AIH, PBC, and controls. We found a higher frequency of the proinflammatory and high-expression \u2212794 CATT7 allele in AIH, compared to PBC, whereas lower frequency was found in PBC, compared to both AIH and healthy controls. MIF and soluble MIF receptor (CD74) were measured by enzyme-linked immunosorbent assay in 165 serum samples of AIH, PBC, and controls. Circulating serum and hepatic MIF expression was elevated in patients with AIH and PBC versus healthy controls. We also identified a truncated circulating form of the MIF receptor, CD74, that is released from hepatic stellate cells and that binds MIF, neutralizing its signal transduction activity. Significantly higher levels of CD74 were found in patients with PBC versus AIH and controls.<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusions\n                                 <\/jats:bold>\n                                 <jats:bold>: These data suggest a distinct genetic and immunopathogenic basis for AIH and PBC at the<\/jats:bold>\n                                 <jats:bold>\n                                    MIF\n                                 <\/jats:bold>\n                                 <jats:bold>locus. Circulating MIF and MIF receptor profiles distinguish PBC from the more inflammatory phenotype of AIH and may play a role in pathogenesis and as biomarkers of these diseases. (Hepatology 2014;59:580\u2013591)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26664","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T12:09:44Z","timestamp":1375445384000},"page":"580-591","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":102,"title":["The Role of Macrophage Migration Inhibitory Factor in Autoimmune Liver Disease"],"prefix":"10.1097","volume":"59","author":[{"given":"David N.","family":"Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence K.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Merk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro Baeza","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McCrann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Mizue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Nikolic-Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bernhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bucala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20250207","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1358\/dnp.2010.23.4.1453629","article-title":"Macrophage migration inhibitory factor (MIF): a promising biomarker.","volume":"23","author":"Grieb","year":"2010","journal-title":"Drug News Perspect"},{"key":"R2-25-20250207","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity.","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R3-25-20250207","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoidinduced modulator of cytokine production.","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"key":"R4-25-20250207","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1210\/me.2007-0065","article-title":"The macrophage migration inhibitory factorglucocorticoid dyad: regulation of inflammation and immunity.","volume":"21","author":"Flaster","year":"2007","journal-title":"Mol Endocrinol"},{"key":"R5-25-20250207","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1002\/art.21285","article-title":"Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.","volume":"52","author":"Radstake","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R6-25-20250207","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.22179","article-title":"Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R7-25-20250207","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2362.2001.00796.x","article-title":"Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.","volume":"31","author":"Murakami","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"R8-25-20250207","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00535-003-1284-7","article-title":"Association of the 173 GC polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.","volume":"39","author":"Nohara","year":"2004","journal-title":"J Gastroenterol"},{"key":"R9-25-20250207","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/art.30624","article-title":"Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.","volume":"63","author":"Sreih","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R10-25-20250207","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"R11-25-20250207","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosisautoimmune hepatitis overlap syndrome.","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-25-20250207","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)63797-2","article-title":"Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.","volume":"162","author":"FingerleRowson","year":"2003","journal-title":"Am J Pathol"},{"key":"R13-25-20250207","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factorCD74 receptor complex.","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"key":"R14-25-20250207","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74.","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"key":"R15-25-20250207","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/bioinformatics\/bth071","article-title":"2LD, GENECOUNTING and HAP: computer programs for linkage disequlibrium analysis.","volume":"20","author":"Zhao","year":"2004","journal-title":"Bioinformatics"},{"key":"R16-25-20250207","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1093\/bioinformatics\/bti529","article-title":"PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data.","volume":"21","author":"Wigginton","year":"2005","journal-title":"Bioinformatics"},{"key":"R17-25-20250207","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis.","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"R18-25-20250207","first-page":"313","article-title":"Primary biliary cirrhosis. N Engl J Med, 2005; 353:1261-1273.","volume":"354","author":"Kaplan","year":"2006","journal-title":"Erratum in N Engl J Med"},{"key":"R19-25-20250207","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1478-3231.2005.01047.x","article-title":"Macrophage migration inhibitor factor expression correlates with inflammatory changes in human chronic hepatitis B infection.","volume":"25","author":"Zhang","year":"2005","journal-title":"Liver Int"},{"key":"R20-25-20250207","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1093\/nar\/gni123","article-title":"Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thinfilm biosensor chips and application to rural field studies.","volume":"33","author":"Zhong","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"R21-25-20250207","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1096\/fj.09-129445","article-title":"The influence of macrophage migration inhibitory factor gene polymorphism on outcome from communityacquired pneumonia.","volume":"23","author":"Yende","year":"2009","journal-title":"FASEB J"},{"key":"R22-25-20250207","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1074\/jbc.R700052200","article-title":"Molecular mechanisms of soluble cytokine receptor generation.","volume":"283","author":"Levine","year":"2008","journal-title":"J Biol Chem"},{"key":"R23-25-20250207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14728222.2011.550879","article-title":"CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.","volume":"15","author":"Borghese","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"R24-25-20250207","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1074-7613(02)00455-7","article-title":"Invariant chaininduced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain.","volume":"17","author":"Matza","year":"2002","journal-title":"Immunity"},{"key":"R25-25-20250207","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1091\/mbc.e05-04-0327","article-title":"CD74 is a member of the regulated intramembrane proteolysisprocessed protein family.","volume":"16","author":"BeckerHermam","year":"2005","journal-title":"Mol Biol Cell"},{"key":"R26-25-20250207","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbamcr.2006.11.005","article-title":"Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFNgamma treatment.","volume":"1773","author":"Maubach","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"R27-25-20250207","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.14.3306","article-title":"Aetiopathogenesis of autoimmune heaptitis.","volume":"14","author":"Vergani","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R28-25-20250207","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.1107023108","article-title":"Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.","volume":"108","author":"Heinrichs","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-25-20250207","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1073\/pnas.93.11.5191","article-title":"Crystal structure at 2.6A resolution of human macrophage migration inhibitory factor.","volume":"93","author":"Sun","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-25-20250207","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1073\/pnas.93.15.7849","article-title":"An essential regulatory role for macrophage migration inhibitory factor in Tcell activation.","volume":"93","author":"Bacher","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-25-20250207","first-page":"927","article-title":"Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.","volume":"34","author":"Kim","year":"2007","journal-title":"J Rheumatol"},{"key":"R32-25-20250207","first-page":"268","article-title":"Macrophage migration inhibitory factor in systemic lupus erythematosus.","volume":"31","author":"Foote","year":"2004","journal-title":"J Rheumatol"},{"key":"R33-25-20250207","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis.","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"R34-25-20250207","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLAencoded susceptibility to type 1 autoimmune hepatitis.","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"R35-25-20250207","first-page":"393","article-title":"Primary biliary cirrhosis: contribution of HLA class II allele DR8.","volume":"86","author":"Gregory","year":"1993","journal-title":"Q J Med"},{"key":"R36-25-20250207","first-page":"2797","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. New Engl J Med, 2009; 360:2544-2555.","volume":"360","author":"Hirschfield","year":"2009","journal-title":"Erratum in N Engl J Med"},{"key":"R37-25-20250207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte4 (CTLA4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"R38-25-20250207","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v10.i20.3056","article-title":"Cytotoxic T lymphocyte associated antigen4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population.","volume":"10","author":"Fan","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R39-25-20250207","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"key":"R40-25-20250207","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/intimm\/6.3.439","article-title":"Transport properties of free and MHC class Ilassociated oligomers containing different isoforms of human invariant chain.","volume":"6","author":"Arunachalam","year":"1994","journal-title":"Int Immunol"},{"key":"R41-25-20250207","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.183.4.1331","article-title":"Major histocompatibility complex class IIassociated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.","volume":"183","author":"Bevec","year":"1996","journal-title":"J Exp Med"},{"key":"R42-25-20250207","doi-asserted-by":"crossref","first-page":"26266","DOI":"10.1074\/jbc.274.37.26266","article-title":"A secreted form of the major histocompatibility complex class IIassociated invariant chain inhibiting T cell activation.","volume":"274","author":"Eynon","year":"1999","journal-title":"J Biol Chem"},{"key":"R43-25-20250207","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/MCB.01907-08","article-title":"A tautomerasenull macrophage migrationinhibitory factor (MIF) gene knockin mouse model reveals that protein interactions and not enzymatic activity mediate MIFdependent growth regulation.","volume":"29","author":"FingerleRowson","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R44-25-20250207","doi-asserted-by":"crossref","first-page":"E577E585","DOI":"10.1073\/pnas.1102941108","article-title":"The Ddopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).","volume":"108","author":"Merk","year":"2011","journal-title":"Proc Nat Acad Sci USA"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26664","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:55:24Z","timestamp":1738947324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201402000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26664","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}